Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.
Isla Pharmaceuticals has raised $2.4M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2024.
Isla Pharmaceuticals's investors include Dr Bill Garner, Angus Walker, Jason Carroll, Chris Ntoumenopolous, Dr Daniel Tillett.
Isla Pharmaceuticals is headquartered in San Juan, Puerto Rico.
Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.
Isla Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Isla Pharmaceuticals — Funding & Investors." VCBacked, October 3, 2024, https://www.vcbacked.co/company/isla-pharmaceuticals. Accessed October 2, 2026.
VCBacked. (2024). Isla Pharmaceuticals — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/isla-pharmaceuticals
{{cite web |title=Isla Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/isla-pharmaceuticals |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated